Patent details
EP1292590 Title: ADMANTANE DERIVATIVES
Basic Information
- Publication number:
- EP1292590
- PCT Application Number:
- PCT/SE/2001/001257
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019389030
- PCT Publication Number:
- WO/2001/094338
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ADMANTANE DERIVATIVES
- French Title of Invention:
- DERIVES D'ADMANTANE
- German Title of Invention:
- ADAMANTANDERIVATE
- SPC Number:
Dates
- Filing date:
- 01/06/2001
- Grant date:
- 18/01/2006
- EP Publication Date:
- 18/01/2006
- PCT Publication Date:
- 13/12/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/03/2003
- EP B1 Publication Date:
- 18/01/2006
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 01/06/2006
- Expiration date:
- 01/06/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/06/2001
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- ALCARAZ Lilian, AstraZeneca R & D Charnwood
- Address:
- United Kingdom (GB)
2
- Name:
- FURBER Mark, AstraZeneca R & D Charnwood
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0013737
- Priority Date:
- 07/06/2000
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- C07D 401/04;
| Filing date | Document type | Number of pages |
|---|